Dabur India Q3 FY26: Revenue up 6.1%, PAT (excl. exceptional items) up 10.1%
Dabur India reported Q3 FY26 consolidated revenue of ₹3,558.6 crore, a 6.1% YoY increase. PAT before exceptional items rose 10.1% to ₹575.0 crore. Key categories like Amla, Honey, and Honitus showed double-digit growth. The company also reported market share gains across several segments.
The results show positive growth, but the presence of operating headwinds and the impact of exceptional items suggest a moderate rather than high impact.
The company reported positive year-on-year growth in revenue and profit, along with market share gains in key categories, indicating a strong operational performance.
Dabur India Limited has announced its financial results for the quarter ended December 31, 2025 (Q3 FY26).
Consolidated revenue grew by 6.1% year-on-year to ₹3,558.6 crore. India FMCG business saw a 6% YoY growth, with a 3% volume growth. International business contributed positively with a 7.5% constant currency (CC) growth.
Operating profit increased by 7.7% YoY to ₹734.1 crore, with a margin expansion of 30 basis points. Profit After Tax (PAT) before exceptional items grew by 10.1% YoY to ₹575.0 crore, with a margin expansion of 60 basis points. The exceptional item, primarily due to the New Labour Code effective November 21, 2025, impacted PAT. Operating profit and PAT growth were ahead of topline growth.
The company reported market share gains across key categories. Double-digit growth was observed in the Amla franchise, Real Activ, Dabur Honey, Dabur Honitus, Dabur Health Juices, and Dabur Meswak. The HPC segment registered strong double-digit growth.
Key growth drivers included strong performance in hair oils (up 19.1%), oral care (around 10% growth for toothpastes, with Dabur Meswak and Dabur Herb’l posting double-digit growth), and health supplements like Dabur Honey (up 10%) and Dabur Honitus (strong double-digit growth). The Foods & Beverages segment also saw double-digit growth, led by culinary products and the Activ range.
Operating headwinds included input cost escalation in key raw materials and transient impacts in October 2025 due to the liquidation of old MRP inventory given revised GST rates. Export and emerging markets were impacted by tariffs and geopolitical disturbances. The discontinuation of Diapers - Baby Super Pants also impacted segment growth.
What to do with a filing like this
Dabur India Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dabur India Limited. Read the original for the full detail.